About Bard
C. R. Bard, Inc., headquartered in Murray Hill, New Jersey, USA, was a developer, manufacturer, and marketer of medical technologies in the vascular medicine, urology, oncology, and surgical specialty fields. C. R. Bard marketed its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. An S&P 500 company with approximately 14,000 employees in 2015, Bard is perhaps best known for having introduced the Foley catheter in 1934.
In April 2017, C. R. Bard announced that it would be acquired by Becton, Dickinson and Company (BD). The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Bard timeline
- 1907
- 🏁· approximateFounded
Events of Bard from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Bard
- Acquisitions and changes
- No longer listed: ticker BCR is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
Not enough history yet.
Sources and freshness
- Profile updated:
- Nov 14, 2026
Figures from Wikidata, Wikipedia, Wikimedia Commons, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Bard? Verify and update this profile — free
Show Bard's ranking on your website Get the badge
The badge updates itself as the ranking changes.